|
Biogen Idec News is an EIN News Service for health professionals. Constantly updated news and information about health.
- InvestorSoup.com Issues Technical Trading Outlook for ARCA biopharma Inc. 25 Nov 2009 12:10 GMT
... ARCA biopharma Inc. (Nasdaq: ) should be of particular interest to other drug manufacturers: Biogen Idec Inc. (Nasdaq: Get our alerts BEFORE the rest of the market. Follow us ...
- Alnylam to Webcast Presentation at Piper Jaffray 21st Annual Health Care Conference 24 Nov 2009 21:51 GMT
... RNAi has enabled it to form major alliances with leading companies including Medtronic, Novartis, Biogen Idec, Roche, Takeda, Kyowa Hakko Kirin, and Cubist. To reflect its outlook for key ...
- Receptos Completes $25M Series A Financing 24 Nov 2009 20:42 GMT
... company leadership team includes co-founders William Rastetter, Ph.D. (partner at Venrock; former executive chairman Biogen Idec, and president and CEO of Idec Pharmaceuticals from its founding), Marcus Boehm, Ph.D. ...
- US midday: Partial recovery in US 24 Nov 2009 18:34 GMT
... Corp. (DISH) $20.60 +1.15% Cephalon Inc. (CEPH) $54.99 +0.97% Verisign Inc. (VRSN) $22.21 +0.86% Biogen Idec Inc. (BIIB) $47.09 +0.64% Nasdaq 100 - Fallers Liberty Global Inc. Series A ...
- ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Expositi 24 Nov 2009 15:32 GMT
... testing through ImmunoGen's collaborations with Genentech (a wholly-owned member of the Roche Group), sanofi-aventis, Biogen Idec and Biotest. The most advanced compound, trastuzumab-DM1 (T-DM1), is in Phase III testing ...
- ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition 24 Nov 2009 15:30 GMT
... testing through ImmunoGen's collaborations with Genentech (a wholly-owned member of the Roche Group), sanofi-aventis, Biogen Idec and Biotest. The most advanced compound, trastuzumab-DM1 (T-DM1), is in Phase III testing ...
- NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 24 Nov 2009 14:30 GMT
... also served as a member of the several governance committees between Genentech and Roche, Biogen Idec, and OSI Pharmaceuticals. From 2001 to 2004, Mr. Orwin achieved increasing responsibility at ...
- New Commander for Joint Task Force Afghanistan 23 Nov 2009 14:54 GMT
... Command of Joint Task Force Afghanistan was transferred ... Task Force Afghanistan was transferred from Brigadier-General (BGen) Jonathan Vance to BGen Daniel Menard during ...
- Option Skews - Relatively Heavy Put Activity on Caterpillar Inc, NVIDIA Corp, Biogen Idec Inc 23 Nov 2009 14:51 GMT
... Option Skews - Relatively Heavy Put Activity on Caterpillar Inc, NVIDIA Corp, Biogen Idec Inc Here are the stocks that saw a bias toward put activity in ...
- Receptos Completes $25M Series A Financing 23 Nov 2009 13:31 GMT
... company leadership team includes co-founders William Rastetter, Ph.D. (partner at Venrock; former executive chairman Biogen Idec, and president and CEO of Idec Pharmaceuticals from its founding), Marcus Boehm, Ph.D. ...
- Analyst Choice Updated Analysis on DENTSPLY International Inc., PAETEC Holding Corp., Antigenics Inc., Cubist Pharmaceuticals Inc., Alkermes Inc. and Biogen Idec Inc. NOTE TO EDITORS: The Following Is an Investment Opinion Being I 23 Nov 2009 12:51 GMT
... DENTSPLY International Inc., PAETEC Holding Corp., Antigenics Inc., Cubist Pharmaceuticals Inc., Alkermes Inc. and Biogen Idec Inc. NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by ...
- Analyst Choice Updated Analysis on DENTSPLY International Inc., PAETEC Holding Corp., Antigenics Inc., Cubist Pharmaceuticals Inc., Alkermes Inc. and Biogen Idec Inc. 23 Nov 2009 12:34 GMT
... Antigenics Inc. (NASDAQ: AGEN), Cubist Pharmaceuticals Inc. (NASDAQ: CBST), Alkermes Inc. (NASDAQ: ALKS) and Biogen Idec Inc. (NASDAQ: BIIB). You can now access these research reports with many others ...
- Analyst Choice Updated Analysis on DENTSPLY International Inc., PAETEC Holding Corp., Antigenics Inc., Cubist Pharmaceuticals Inc., Alkermes Inc. and Biogen Idec Inc. (MRW) 23 Nov 2009 12:32 GMT
... To see if our analysts believe you should BUY, SELL or HOLD these six stocks sign ...
- Analyst Choice Updated Analysis on DENTSPLY International Inc., PAETEC Holding Corp., Antigenics Inc 23 Nov 2009 12:32 GMT
... DENTSPLY International Inc., PAETEC Holding Corp., Antigenics Inc., Cubist Pharmaceuticals Inc., Alkermes Inc. and Biogen Idec Inc. Analyst Choice Updated Analysis on DENTSPLY International Inc., PAETEC Holding Corp., Antigenics ...
- New Whitepaper: 'The Benefits of Microblogging in the Enterprise' 22 Nov 2009 22:01 GMT
... widget services are in use by hundreds of the world's most recognized brands, including Biogen Idec, CBS, CNN, Discovery, National Geographic, Procter & Gamble and USA Today. NewsGator Social ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Healthcare Industry Today
|
a digital news provider
reuters.com:
ap.org:
msnbc.msn.com:
healthday.com:
bbc.co.uk: